• Events
    • Future Meetings
    • Digital Events
    • EURETINA 2022 Hamburg
      • Browse Programme
      • Registration Information
      • Hotel Bookings
    • EURETINA 2021 Virtual
      • 2021 Virtual Sessions On-Demand (Members Only)
      • Programme
      • Satellite Symposia
      • Sponsors
  • Free Resources
    • Webinars
    • Podcasts
    • 2021 Virtual Session Abstracts
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • Mentorship Programme 2022/23
    • RMCR grant programme
    • Observership Grant Programme
    • Women in Retina
    • YOURS
    • CME Credits
  • Member Login
Menu
  • Events
    • Future Meetings
    • Digital Events
    • EURETINA 2022 Hamburg
      • Browse Programme
      • Registration Information
      • Hotel Bookings
    • EURETINA 2021 Virtual
      • 2021 Virtual Sessions On-Demand (Members Only)
      • Programme
      • Satellite Symposia
      • Sponsors
  • Free Resources
    • Webinars
    • Podcasts
    • 2021 Virtual Session Abstracts
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • Mentorship Programme 2022/23
    • RMCR grant programme
    • Observership Grant Programme
    • Women in Retina
    • YOURS
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Quantification by SS-OCT and OCT-A of the changes induced by photodynamic therapy in patients with chronic central serous choroidopathy.

Author: María Dolores Díaz Barreda (Spain)

Co-authors: Ana Boned Murillo, Guillermo Pérez Rivasés, Ismael Bakkali El Bakkali, Francisco Javier Ascaso Puyuelo, Ana Honrubia Grijalbo, Olivia Esteban Floría

Purpose

To characterize the response to low-fluence photodynamic therapy (PDT) in patients with chronic central serous choroidopathy (CSC) in functional (visual acuity; VA) and anatomical terms using swept-source optical coherence tomography (SS-OCT) and OCT angiography (OCT-A).

Setting/Venue

Although the pathophysiology is not fully understood, central serous chorioretinopathy (CSC) has been linked to choroidal hyperpermeability typically resulting in neurosensory detachment and/or detachment of the retinal pigment epithelium at the posterior pole. Chronic cases must be treated to avoid visual impairment. In recent years, new therapeutic strategies have appeared in conjunction with improved diagnostics and the development of new imaging techniques. The most commonly used are photodynamic therapy with verteporfin, subthreshold micropulse laser, treatment with mineralocorticoid antagonists or intravitreal antiangiogenic drugs, the results and possible adverse effects of which are not yet well defined in these cases.

Methods

Retrospective study of 42 eyes with chronic CSC more than 8±1.2 months treated with low-fluence PDT and assessed at 1, 3, 6, 12 and 36 months after treatment by OCT and OCT-A. Patients with previous ocular pathologies, refractive errors greater than 3 dioptres or who had received any type of previous intraocular treatment were excluded.

Results

Forty-two eyes with chronic CSC belonging to 38 patients (77.7% male and 22.3% female) with a mean age of 49.5 ± 8.0 years and a mean VA according to the decimal scale of 0.64 ± 0.22 were studied. Mean VA improved to 0.85 ± 1.2 after 1 month of treatment and remained stable until the end of the follow-up period (p<0.05). Foveal retinal thickness was significantly lower after 1 month of PDT treatment and remained stable until 36 months (p<0.05). Foveal choroidal thickness was reduced after one month of treatment and maintained similar values until the end of follow-up (p>0.05). Perifoveal macular retinal and choroidal macular sectors improved after PDT and remained stable until the end of follow-up. Only two patients needed a second PDT after 12 months. At 36 months, two patients (4.7%) presented choroidal neovascularization by OCT-A and two other patients had subretinal fluid again.

Conlusions

Low-fluence PDT showed a rapid (first month) and long-lasting (sustained 36 months follow-up) improvement in the treatment of chronic CSC, both in terms of VA and macular thickness (retinal and choroidal). Only 4.7% of the sample showed choroidal neovasularization with OCT-A after 36 months of follow-up.

Financial Disclosure

None

Comments

-

Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building 
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2

Phone:+353 1 2100092
Email: [email protected]

EURETINA 2022 Hamburg

Opportunities

Memberships

Forum

About

Privacy Policy

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2021 All rights reserved
  • Events
    • Future Meetings
    • Digital Events
    • EURETINA 2022 Hamburg
      • Browse Programme
      • Registration Information
      • Hotel Bookings
    • EURETINA 2021 Virtual
      • 2021 Virtual Sessions On-Demand (Members Only)
      • Programme
      • Satellite Symposia
      • Sponsors
  • Free Resources
    • Webinars
    • Podcasts
    • 2021 Virtual Session Abstracts
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • Mentorship Programme 2022/23
    • RMCR grant programme
    • Observership Grant Programme
    • Women in Retina
    • YOURS
    • CME Credits
  • Member Login